At close: December 19 at 4:00:02 PM EST
After hours: 7:47:31 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-8,294.0000
-58,789.0000
-146,912.0000
-203,354.0000
-184,820.0000
Investing Cash Flow
-1,540.0000
17,995.0000
-3,324.0000
32,729.0000
208,955.0000
Financing Cash Flow
716.0000
54,107.0000
75,059.0000
156,028.0000
9,105.0000
End Cash Position
25,741.0000
28,677.0000
15,364.0000
90,541.0000
105,138.0000
Interest Paid Supplemental Data
4,859.0000
3,059.0000
2,250.0000
1,244.0000
--
Capital Expenditure
-1,318.0000
-1,545.0000
-1,825.0000
-3,022.0000
-6,813.0000
Issuance of Capital Stock
--
29,755.0000
75,145.0000
--
--
Issuance of Debt
--
24,350.0000
--
148,963.0000
26.0000
Free Cash Flow
-9,612.0000
-60,334.0000
-148,737.0000
-206,376.0000
-191,633.0000
12/31/2020 - 8/26/1987
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
KPTI Karyopharm Therapeutics Inc.
0.6496
-1.92%
VNDA Vanda Pharmaceuticals Inc.
4.6300
+1.76%
CHRS Coherus BioSciences, Inc.
1.4800
-5.73%
ATRA Atara Biotherapeutics, Inc.
9.93
+1.22%
ARDX Ardelyx, Inc.
4.6900
+1.74%
MREO Mereo BioPharma Group plc
3.2900
-0.60%
AFMD Affimed N.V.
1.1800
-6.35%
CMRX Chimerix, Inc.
2.8500
+5.17%
APLT Applied Therapeutics, Inc.
1.0200
-5.56%
VTYX Ventyx Biosciences, Inc.
2.2800
-0.87%